Z.-H. . Chen, “Serological Thymidine Kinase1 is a Biomarker for Early Risk of Tumours Progression —Real World Data from a Health Screening Study on a Cohort of 35,365 People”, NUPSR-V5, pp. 36–65, May 2021.